{"id":1015237,"date":"2026-10-29T12:37:34","date_gmt":"2026-10-29T16:37:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/"},"modified":"2026-10-29T12:37:34","modified_gmt":"2026-10-29T16:37:34","slug":"lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","title":{"rendered":"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026"},"content":{"rendered":"
\n

THE WOODLANDS, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc.<\/a> (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced the Company will release its\u00a0third quarter 2026\u00a0financial results on\u00a0Thursday,\u00a0November 5, 2026,\u00a0prior to\u00a0market\u00a0open. Management will conduct a conference call and live webcast at\u00a08:30\u00a0a.m. ET (7:30\u00a0a.m. CT) that day to discuss the financial results and to provide a business update.\u00a0<\/p>\n

Participants can access the conference call live via webcast on the Events page of the Company\u2019s website at\u00a0https:\/\/investors.lexpharma.com\/<\/a>. Participants who wish to ask a question may\u00a0register here<\/a>\u00a0to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website.<\/p>\n

\n About Lexicon Pharmaceuticals<\/strong>
\n
Lexicon Pharmaceuticals is a biopharmaceutical company pursuing novel medicines for patients with serious cardiometabolic diseases. Building on a proven legacy in genetic target discovery, Lexicon is advancing a clinical pipeline in areas of significant and often underserved need, with programs in hypertrophic cardiomyopathy (HCM), type 1 diabetes (T1D), obesity and other related metabolic conditions. Lexicon is committed to developing differentiated therapies that can be integrated broadly into clinical practice, with the goal of expanding treatment options for patients. Its capabilities extend from early-stage target discovery through clinical development and commercialization, strategically paired with high-impact collaborations to maximize the global reach of its medicines.<\/p>\n

For\u00a0additional\u00a0information, please visit\u00a0www.lexpharma.com<\/a>.\u00a0\u00a0\u00a0<\/strong><\/p>\n

\n For Media Inquiries:<\/strong>
\n
Dave Belian
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com<\/a><\/p>\n

\n For Investor Inquiries:<\/strong>
\n
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

THE WOODLANDS, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced the Company will release its\u00a0third quarter 2026\u00a0financial results on\u00a0Thursday,\u00a0November 5, 2026,\u00a0prior to\u00a0market\u00a0open. Management will conduct a conference call and live webcast at\u00a08:30\u00a0a.m. ET (7:30\u00a0a.m. CT) that day to discuss the financial results and to provide a business update.\u00a0 Participants can access the conference call live via webcast on the Events page of the Company\u2019s website at\u00a0https:\/\/investors.lexpharma.com\/. Participants who wish to ask a question may\u00a0register here\u00a0to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website. About Lexicon Pharmaceuticals Lexicon Pharmaceuticals is a biopharmaceutical company pursuing … <\/p>\n

Continue reading “Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1015237","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"THE WOODLANDS, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced the Company will release its\u00a0third quarter 2026\u00a0financial results on\u00a0Thursday,\u00a0November 5, 2026,\u00a0prior to\u00a0market\u00a0open. Management will conduct a conference call and live webcast at\u00a08:30\u00a0a.m. ET (7:30\u00a0a.m. CT) that day to discuss the financial results and to provide a business update.\u00a0 Participants can access the conference call live via webcast on the Events page of the Company\u2019s website at\u00a0https:\/\/investors.lexpharma.com\/. Participants who wish to ask a question may\u00a0register here\u00a0to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website. About Lexicon Pharmaceuticals Lexicon Pharmaceuticals is a biopharmaceutical company pursuing … Continue reading "Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-29T16:37:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026\",\"datePublished\":\"2026-10-29T16:37:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\"},\"wordCount\":266,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\",\"name\":\"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc=\",\"datePublished\":\"2026-10-29T16:37:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","og_locale":"en_US","og_type":"article","og_title":"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk","og_description":"THE WOODLANDS, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced the Company will release its\u00a0third quarter 2026\u00a0financial results on\u00a0Thursday,\u00a0November 5, 2026,\u00a0prior to\u00a0market\u00a0open. Management will conduct a conference call and live webcast at\u00a08:30\u00a0a.m. ET (7:30\u00a0a.m. CT) that day to discuss the financial results and to provide a business update.\u00a0 Participants can access the conference call live via webcast on the Events page of the Company\u2019s website at\u00a0https:\/\/investors.lexpharma.com\/. Participants who wish to ask a question may\u00a0register here\u00a0to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website. About Lexicon Pharmaceuticals Lexicon Pharmaceuticals is a biopharmaceutical company pursuing … Continue reading \"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-29T16:37:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026","datePublished":"2026-10-29T16:37:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/"},"wordCount":266,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","name":"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc=","datePublished":"2026-10-29T16:37:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTYyMSM3OTIyNzc3IzIwMDM5Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lexicon-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1015237"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015237\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1015237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1015237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1015237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}